A Phase II study of M119102 for alopecia areata

JRCT ID: jRCT2061220077

Registered date:23/12/2022

Basic Information

• Recruitment status: Not Recruiting
• Health condition(s) or Problem(s) studied: Alopecia Areata
• Date of first enrollment: 20/03/2023
• Target sample size: 25
• Study type: Interventional
• Intervention(s): Apply an appropriate amount of M119102 to on the lesion

Outcome(s)

• Primary Outcome: LAD,SALT

Key inclusion & exclusion criteria

• Age minimum: >= 12age old
• Age maximum: < 65age old
• Gender: Both
• Include criteria: Patients with alopecia areata 12 to 64 years old

Exclude criteria

1)Individuals with a history or merger of hepatic, renal, cardiac and other cardiovascular, gastrointestinal, hematologic, blood, endocrine, respiratory, or other diseases considered inappropriate for paticipation in the clinical study.
(2)Individuals who are judged to be unsuitable as subject by the principal (sub) investigator.

Related Information

• Primary Sponsor: Tomoyuki Nishiura